Back
15
Day Range
$7.94
$42.00
52-Week Range
$7.94
$42.00
Volume
3,000
50D / 200D Avg
$42.00
/
$42.00
Prev Close
$42.00
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 8.8 | 0.2 |
| P/B | 0.9 | 3.0 |
| ROE % | 10.4 | 3.6 |
| Net Margin % | 5.4 | 3.8 |
| Rev Growth 5Y % | 6.9 | 9.9 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$0.94
$0.94 – $0.94
|
11.93B | 1 |
| FY2027 |
$0.84
$0.84 – $0.84
|
11.47B | 1 |
| FY2026 |
$0.78
$0.78 – $0.78
|
10.78B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-04 | $0.19 | $0.23 | +20.5% |
| 2025-10-23 | $0.13 | $0.14 | +5.4% |
| 2025-07-15 | $0.18 | $0.09 | -52.0% |
| 2025-04-25 | $0.16 | $0.10 | -40.0% |
| 2025-02-05 | $0.12 | $0.07 | -43.9% |
| 2024-10-23 | $0.11 | $0.02 | -82.8% |
| 2024-07-12 | $0.13 | $0.06 | -55.9% |
| 2024-05-08 | $0.13 | $0.05 | -64.2% |
Dividend History
6 yr streakYield
0.00%
Payout Ratio
0.16%
Growth (3Y)
-24.49%
Growth (5Y)
-19.67%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 12, 2025 | May 15, 2025 | $0.08 | 0.19% |
| May 10, 2024 | May 16, 2024 | $0.05 | 0.12% |
| May 06, 2022 | May 12, 2022 | $0.20 | 0.50% |
| May 06, 2021 | May 12, 2021 | $0.18 | 0.91% |
| Nov 20, 2020 | Nov 26, 2020 | $0.06 | 0.30% |
| May 10, 2019 | May 16, 2019 | $0.23 | 0.92% |
| Jun 01, 2018 | Jun 08, 2018 | $0.25 | 1.19% |
| May 30, 2017 | Jun 05, 2017 | $0.17 | 0.82% |
Key Takeaways
Revenue grew 6.91% annually over 5 years — modest growth
Earnings grew 122.22% over the past year
ROE of 10.42% — decent returns on equity
Debt/Equity of 0.00 — conservative balance sheet
Generating 1.39B in free cash flow
P/E of 8.80 — trading at a low valuation
Growth
Revenue Growth (5Y)
6.91%
Revenue (1Y)1.52%
Earnings (1Y)122.22%
FCF Growth (3Y)73.02%
Quality
Return on Equity
10.42%
ROIC13.68%
Net Margin5.36%
Op. Margin9.51%
Safety
Debt / Equity
0.00
Current Ratio1.04
Interest Coverage0.00
Valuation
P/E Ratio
8.80
Forward P/E53.92
P/B Ratio0.91
EV/EBITDA4.14
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.52% | Revenue Growth (3Y) | 3.83% |
| Earnings Growth (1Y) | 122.22% | Earnings Growth (3Y) | 71.68% |
| Revenue Growth (5Y) | 6.91% | Earnings Growth (5Y) | -6.06% |
| Profitability | |||
| Revenue (TTM) | 10.44B | Net Income (TTM) | 560.00M |
| ROE | 10.42% | ROA | 4.41% |
| Gross Margin | 38.09% | Operating Margin | 9.51% |
| Net Margin | 5.36% | Free Cash Flow (TTM) | 1.39B |
| ROIC | 13.68% | FCF Growth (3Y) | 73.02% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 1.04 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.16% |
| Dividend Growth (3Y) | -24.49% | Dividend Growth (5Y) | -19.67% |
| Consecutive Div Years | 6 yrs | ||
| Valuation | |||
| P/E Ratio | 8.80 | Forward P/E | 53.92 |
| P/B Ratio | 0.91 | P/S Ratio | 0.47 |
| PEG Ratio | 0.69 | Forward PEG | N/A |
| EV/EBITDA | 4.14 | Fwd EV/EBITDA | 2.58 |
| Forward P/S | 0.46 | Fwd Earnings Yield | 1.85% |
| FCF Yield | 28.26% | ||
| Market Cap | 4.93B | Enterprise Value | 4.11B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10.44B | 10.29B | 9.69B | 9.08B | 7.99B |
| Net Income | 560.00M | 252.00M | 190.00M | 480.00M | 719.00M |
| EPS (Diluted) | 4.59 | 2.07 | 1.56 | 3.95 | 6.01 |
| Gross Profit | 3.98B | 3.86B | 3.60B | 3.43B | 2.86B |
| Operating Income | 993.00M | 721.00M | 585.00M | 808.00M | 996.30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12.71B | 13.06B | 12.75B | 13.06B | 10.60B |
| Total Liabilities | 7.26B | 7.75B | 7.79B | 8.09B | 6.30B |
| Shareholders' Equity | 5.44B | 5.31B | 4.96B | 4.97B | 4.29B |
| Total Debt | 0.0 | 5.07B | 5.29B | 5.59B | 4.10B |
| Cash & Equivalents | 813.00M | 331.00M | 272.00M | 376.00M | 345.30M |
| Current Assets | 4.15B | 3.93B | 3.61B | 3.57B | 2.75B |
| Current Liabilities | 3.99B | 3.19B | 4.31B | 4.46B | 4.91B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#764 of 826
Recent Activity
Exited
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered
Defensive Investing (Benjamin Graham)
Mar 24, 2026